vs

Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Neptune Insurance Holdings Inc. (NP). Click either name above to swap in a different company.

Neptune Insurance Holdings Inc. is the larger business by last-quarter revenue ($37.8M vs $31.1M, roughly 1.2× LIFECORE BIOMEDICAL, INC. \DE\). Neptune Insurance Holdings Inc. runs the higher net margin — 0.1% vs -32.1%, a 32.2% gap on every dollar of revenue. On growth, Neptune Insurance Holdings Inc. posted the faster year-over-year revenue change (28.8% vs -4.5%).

LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.

Neptune Insurance Holdings Inc. is a specialty insurance holding company that offers a broad portfolio of property and casualty insurance products, with a core focus on residential and commercial flood insurance for customers across the United States. It serves both individual consumers and small to mid-sized business clients, using advanced data analytics to support accurate policy pricing and robust risk management.

LFCR vs NP — Head-to-Head

Bigger by revenue
NP
NP
1.2× larger
NP
$37.8M
$31.1M
LFCR
Growing faster (revenue YoY)
NP
NP
+33.2% gap
NP
28.8%
-4.5%
LFCR
Higher net margin
NP
NP
32.2% more per $
NP
0.1%
-32.1%
LFCR

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
LFCR
LFCR
NP
NP
Revenue
$31.1M
$37.8M
Net Profit
$-10.0M
$50.0K
Gross Margin
25.0%
Operating Margin
-9.9%
Net Margin
-32.1%
0.1%
Revenue YoY
-4.5%
28.8%
Net Profit YoY
-52.0%
0.0%
EPS (diluted)
$-0.29
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LFCR
LFCR
NP
NP
Q1 26
$37.8M
Q3 25
$31.1M
$44.4M
Q1 25
$35.2M
Q4 24
$32.6M
Q3 24
$24.7M
$33.8M
Q1 24
$35.7M
Q4 23
$30.1M
Q3 23
$24.5M
Net Profit
LFCR
LFCR
NP
NP
Q1 26
$50.0K
Q3 25
$-10.0M
$11.5M
Q1 25
$-14.8M
Q4 24
$-6.6M
Q3 24
$-16.2M
$12.1M
Q1 24
$15.6M
Q4 23
$14.2M
Q3 23
$-10.8M
Gross Margin
LFCR
LFCR
NP
NP
Q1 26
Q3 25
25.0%
Q1 25
28.0%
Q4 24
34.0%
Q3 24
21.8%
Q1 24
33.3%
Q4 23
33.0%
Q3 23
11.1%
Operating Margin
LFCR
LFCR
NP
NP
Q1 26
Q3 25
-9.9%
46.7%
Q1 25
-25.7%
Q4 24
-6.0%
Q3 24
-46.9%
58.6%
Q1 24
-2.5%
Q4 23
-4.9%
Q3 23
-35.1%
Net Margin
LFCR
LFCR
NP
NP
Q1 26
0.1%
Q3 25
-32.1%
25.9%
Q1 25
-42.0%
Q4 24
-20.2%
Q3 24
-65.7%
35.8%
Q1 24
43.8%
Q4 23
47.2%
Q3 23
-43.9%
EPS (diluted)
LFCR
LFCR
NP
NP
Q1 26
$0.05
Q3 25
$-0.29
$0.06
Q1 25
$-0.47
Q4 24
$-0.25
Q3 24
$-0.53
$0.06
Q1 24
$0.42
Q4 23
$0.39
Q3 23
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LFCR
LFCR
NP
NP
Cash + ST InvestmentsLiquidity on hand
$18.9M
Total DebtLower is stronger
$136.0M
Stockholders' EquityBook value
$-10.5M
Total Assets
$235.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LFCR
LFCR
NP
NP
Q1 26
Q3 25
$18.9M
$12.2M
Q1 25
$5.4M
Q4 24
$9.5M
Q3 24
Q1 24
Q4 23
Q3 23
Total Debt
LFCR
LFCR
NP
NP
Q1 26
Q3 25
$136.0M
$247.6M
Q1 25
$124.9M
Q4 24
$111.3M
Q3 24
$106.3M
Q1 24
$97.1M
Q4 23
$92.9M
Q3 23
$88.8M
Stockholders' Equity
LFCR
LFCR
NP
NP
Q1 26
Q3 25
$-10.5M
$-509.5M
Q1 25
$2.2M
Q4 24
$15.4M
Q3 24
$-3.9M
$-374.3M
Q1 24
$17.7M
Q4 23
$1.4M
Q3 23
$-13.6M
Total Assets
LFCR
LFCR
NP
NP
Q1 26
Q3 25
$235.2M
$89.6M
Q1 25
$237.7M
Q4 24
$255.4M
Q3 24
$246.8M
Q1 24
$246.2M
Q4 23
$245.8M
Q3 23
$245.6M
Debt / Equity
LFCR
LFCR
NP
NP
Q1 26
Q3 25
Q1 25
56.05×
Q4 24
7.20×
Q3 24
Q1 24
5.49×
Q4 23
65.35×
Q3 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LFCR
LFCR
NP
NP
Operating Cash FlowLast quarter
$1.8M
Free Cash FlowOCF − Capex
$25.0K
FCF MarginFCF / Revenue
0.1%
Capex IntensityCapex / Revenue
5.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-16.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LFCR
LFCR
NP
NP
Q1 26
Q3 25
$1.8M
$38.9M
Q1 25
$1.2M
Q4 24
$-6.1M
Q3 24
$-613.0K
Q1 24
$-1.4M
Q4 23
$1.3M
Q3 23
$-8.3M
Free Cash Flow
LFCR
LFCR
NP
NP
Q1 26
Q3 25
$25.0K
Q1 25
$-4.3M
Q4 24
$-8.6M
Q3 24
$-4.0M
Q1 24
$-7.8M
Q4 23
$-3.0M
Q3 23
$-13.4M
FCF Margin
LFCR
LFCR
NP
NP
Q1 26
Q3 25
0.1%
Q1 25
-12.1%
Q4 24
-26.3%
Q3 24
-16.3%
Q1 24
-21.8%
Q4 23
-9.9%
Q3 23
-54.6%
Capex Intensity
LFCR
LFCR
NP
NP
Q1 26
Q3 25
5.6%
Q1 25
15.5%
Q4 24
7.5%
Q3 24
13.9%
Q1 24
17.8%
Q4 23
14.1%
Q3 23
20.6%
Cash Conversion
LFCR
LFCR
NP
NP
Q1 26
Q3 25
3.38×
Q1 25
Q4 24
Q3 24
Q1 24
-0.09×
Q4 23
0.09×
Q3 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LFCR
LFCR

Transferred At Point In Time$26.6M85%
Transferred Over Time$4.5M15%

NP
NP

Segment breakdown not available.

Related Comparisons